Effects of immune system on MRE ingreadients(fermentative degradation substances) liquid intake an open-label, randomized controlled trial
- Conditions
- healthy individuals
- Registration Number
- JPRN-UMIN000037831
- Lead Sponsor
- Miura Clinic, Medical Corporation Kanonkai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 40
Not provided
(1) Subjects with a history of liver disease, kidney disease, gastrointestinal disease, heart disease, or other diseases that may affect the results of this study, or subjects with a history of surgery (2) Subjects with a disease currently being treated (3) Subjects with food and drug allergies (4) Subjects who have a habit of eating and drinking (5) Those who play intense sports and subjects who are on a diet (6) Subjects taking health foods and medicines that are expected to improve immunity and bowel movement (7) Subjects who may overdose food with a bowel movement improving effect during the study period (8) Subjects with anemia (9) Subjects whose life is irregular (10) Subjects who can not quit the intake of health food (including food for FOSHU and Foods with Function Claims') and designated quasi-drugs during the test period (11) Subjects who are taking medication (OTC drugs, including prescription drugs) continuously (12) Subjects who are excessively consuming alcohol or subjects who cannot ban alcohol from the day before the test to the day (13) Pregnant subjects or subjects who plan to become pregnant or breastfeed during the study period (14) Subjects who have participated in other clinical studies within 4 weeks from the start of this study, subjects who are currently participating in or plan to participate in the study (15) Subjects whose stool volume is equivalent to 1 or less quail eggs (16) Other subjects judged by the investigator as inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plasma metabolome analysis Natural killer cell activity Defecation status
- Secondary Outcome Measures
Name Time Method Visual Analogue Scale Chalder's fatigue scale Profile of Mood States 2nd Edition (Fecal metabolome analysis, Fecal IgA, *Consider whether the analysis will be performed after the test.)